734150006: Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product (product)\Medicinal product (product)\...

\Medicinal product categorized by disposition (product)\Product containing enzyme inhibitor (product)\...

\Cytochrome P450 inhibitor-containing product\Product containing cobicistat (medicinal product)\...

\Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)
\Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)

\Cobicistat-containing product in oral dose form\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)

\Product containing transferase inhibitor (product)\Product containing nucleotidyltransferase inhibitor (product)\Product containing integrase strand transfer inhibitor (product)\Product containing elvitegravir (medicinal product)\Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)
\Product containing transferase inhibitor (product)\Product containing nucleotidyltransferase inhibitor (product)\Product containing integrase strand transfer inhibitor (product)\Product containing elvitegravir (medicinal product)\Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)
\Product containing transferase inhibitor (product)\Product containing nucleotidyltransferase inhibitor (product)\Product containing integrase strand transfer inhibitor (product)\Product containing elvitegravir (medicinal product)\Elvitegravir-containing product in oral dose form\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)
\Product containing transferase inhibitor (product)\Product containing reverse transcriptase inhibitor (product)\Product containing emtricitabine (medicinal product)\Emtricitabine-containing product in oral dose form\Product containing emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)
\Product containing transferase inhibitor (product)\Product containing reverse transcriptase inhibitor (product)\Product containing emtricitabine (medicinal product)\Product containing emtricitabine and tenofovir (medicinal product)\Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)
\Product containing transferase inhibitor (product)\Product containing reverse transcriptase inhibitor (product)\Product containing emtricitabine (medicinal product)\Product containing emtricitabine and tenofovir (medicinal product)\Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)
\Product containing transferase inhibitor (product)\Product containing reverse transcriptase inhibitor (product)\Product containing emtricitabine (medicinal product)\Product containing emtricitabine and tenofovir (medicinal product)\Product containing emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)
\Product containing transferase inhibitor (product)\Product containing reverse transcriptase inhibitor (product)\Product containing tenofovir (medicinal product)\Product containing tenofovir in oral dose form (medicinal product form)\Product containing emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)
\Product containing transferase inhibitor (product)\Product containing reverse transcriptase inhibitor (product)\Product containing tenofovir (medicinal product)\Product containing emtricitabine and tenofovir (medicinal product)\Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)
\Product containing transferase inhibitor (product)\Product containing reverse transcriptase inhibitor (product)\Product containing tenofovir (medicinal product)\Product containing emtricitabine and tenofovir (medicinal product)\Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)
\Product containing transferase inhibitor (product)\Product containing reverse transcriptase inhibitor (product)\Product containing tenofovir (medicinal product)\Product containing emtricitabine and tenofovir (medicinal product)\Product containing emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)

\Medicinal product categorized by structure\Ether structure-containing product\Product containing elvitegravir (medicinal product)\Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure\Ether structure-containing product\Product containing elvitegravir (medicinal product)\Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure\Ether structure-containing product\Product containing elvitegravir (medicinal product)\Elvitegravir-containing product in oral dose form\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure\Product containing organic acid and/or organic acid derivative (product)\Carboxylic acid and/or carboxylic acid derivative-containing product\Product containing carbamate (product)\Product containing cobicistat (medicinal product)\Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure\Product containing organic acid and/or organic acid derivative (product)\Carboxylic acid and/or carboxylic acid derivative-containing product\Product containing carbamate (product)\Product containing cobicistat (medicinal product)\Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure\Product containing organic acid and/or organic acid derivative (product)\Carboxylic acid and/or carboxylic acid derivative-containing product\Product containing carbamate (product)\Product containing cobicistat (medicinal product)\Cobicistat-containing product in oral dose form\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure\Product containing organic acid and/or organic acid derivative (product)\Carboxylic acid and/or carboxylic acid derivative-containing product\Product containing tenofovir (medicinal product)\Product containing tenofovir in oral dose form (medicinal product form)\Product containing emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure\Product containing organic acid and/or organic acid derivative (product)\Carboxylic acid and/or carboxylic acid derivative-containing product\Product containing tenofovir (medicinal product)\Product containing emtricitabine and tenofovir (medicinal product)\Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure\Product containing organic acid and/or organic acid derivative (product)\Carboxylic acid and/or carboxylic acid derivative-containing product\Product containing tenofovir (medicinal product)\Product containing emtricitabine and tenofovir (medicinal product)\Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure\Product containing organic acid and/or organic acid derivative (product)\Carboxylic acid and/or carboxylic acid derivative-containing product\Product containing tenofovir (medicinal product)\Product containing emtricitabine and tenofovir (medicinal product)\Product containing emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure\Urea and/or urea derivative-containing product\Product containing cobicistat (medicinal product)\Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure\Urea and/or urea derivative-containing product\Product containing cobicistat (medicinal product)\Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure\Urea and/or urea derivative-containing product\Product containing cobicistat (medicinal product)\Cobicistat-containing product in oral dose form\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure\Chlorine and/or chlorine compound-containing product\Product containing chlorinated hydrocarbon (product)\Product containing elvitegravir (medicinal product)\Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure\Chlorine and/or chlorine compound-containing product\Product containing chlorinated hydrocarbon (product)\Product containing elvitegravir (medicinal product)\Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure\Chlorine and/or chlorine compound-containing product\Product containing chlorinated hydrocarbon (product)\Product containing elvitegravir (medicinal product)\Elvitegravir-containing product in oral dose form\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing pyrimidine (product)\Product containing emtricitabine (medicinal product)\Emtricitabine-containing product in oral dose form\Product containing emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing pyrimidine (product)\Product containing emtricitabine (medicinal product)\Product containing emtricitabine and tenofovir (medicinal product)\Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing pyrimidine (product)\Product containing emtricitabine (medicinal product)\Product containing emtricitabine and tenofovir (medicinal product)\Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing pyrimidine (product)\Product containing emtricitabine (medicinal product)\Product containing emtricitabine and tenofovir (medicinal product)\Product containing emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing quinoline (product)\Product containing elvitegravir (medicinal product)\Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing quinoline (product)\Product containing elvitegravir (medicinal product)\Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing quinoline (product)\Product containing elvitegravir (medicinal product)\Elvitegravir-containing product in oral dose form\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure\Product containing halogenated hydrocarbon (product)\Product containing chlorinated hydrocarbon (product)\Product containing elvitegravir (medicinal product)\Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure\Product containing halogenated hydrocarbon (product)\Product containing chlorinated hydrocarbon (product)\Product containing elvitegravir (medicinal product)\Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure\Product containing halogenated hydrocarbon (product)\Product containing chlorinated hydrocarbon (product)\Product containing elvitegravir (medicinal product)\Elvitegravir-containing product in oral dose form\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure\Product containing sulfur and/or sulfur compound (product)\Product containing thiazole (product)\Product containing cobicistat (medicinal product)\Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure\Product containing sulfur and/or sulfur compound (product)\Product containing thiazole (product)\Product containing cobicistat (medicinal product)\Product containing cobicistat and elvitegravir and emtricitabine and tenofovir (medicinal product)\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)
\Medicinal product categorized by structure\Product containing sulfur and/or sulfur compound (product)\Product containing thiazole (product)\Product containing cobicistat (medicinal product)\Cobicistat-containing product in oral dose form\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)

\Product manufactured as oral dose form (product)\Emtricitabine-containing product in oral dose form\Product containing emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)
\Product manufactured as oral dose form (product)\Elvitegravir-containing product in oral dose form\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)
\Product manufactured as oral dose form (product)\Cobicistat-containing product in oral dose form\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)
\Product manufactured as oral dose form (product)\Product containing tenofovir in oral dose form (medicinal product form)\Product containing emtricitabine and tenofovir in oral dose form (medicinal product form)\Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form\Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)\Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2017. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

5183296017 Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

5183299012 Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	Is a	Cobicistat- and elvitegravir- and emtricitabine- and tenofovir-containing product in oral dose form	false	Inferred relationship	Some
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	Has manufactured dose form	Oral tablet	true	Inferred relationship	Some
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	This attribute specifies the numerator unit for the presentation strength of a product.	mg	false	Inferred relationship	Some	5
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	un	false	Inferred relationship	Some	5
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	This attribute specifies the denominator unit for the presentation strength of a product.	Tablet (unit of presentation)	false	Inferred relationship	Some	5
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	This attribute specifies the numerator unit for the presentation strength of a product.	mg	false	Inferred relationship	Some	6
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	un	false	Inferred relationship	Some	6
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	This attribute specifies the denominator unit for the presentation strength of a product.	Tablet (unit of presentation)	false	Inferred relationship	Some	6
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	This attribute specifies the numerator unit for the presentation strength of a product.	mg	false	Inferred relationship	Some	7
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	un	false	Inferred relationship	Some	7
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	This attribute specifies the denominator unit for the presentation strength of a product.	Tablet (unit of presentation)	false	Inferred relationship	Some	7
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Cobicistat	false	Inferred relationship	Some	8
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	Cobicistat	false	Inferred relationship	Some	8
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength numerator value	150	false	Inferred relationship	Some	8
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	This attribute specifies the numerator unit for the presentation strength of a product.	mg	false	Inferred relationship	Some	8
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	un	false	Inferred relationship	Some	8
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	This attribute specifies the denominator unit for the presentation strength of a product.	Tablet (unit of presentation)	false	Inferred relationship	Some	8
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Elvitegravir (substance)	false	Inferred relationship	Some	6
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	Elvitegravir (substance)	false	Inferred relationship	Some	6
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength numerator value	150	false	Inferred relationship	Some	6
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Emtricitabine (substance)	false	Inferred relationship	Some	7
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	Emtricitabine (substance)	false	Inferred relationship	Some	7
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength numerator value	200	false	Inferred relationship	Some	7
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Tenofovir alafenamide (substance)	false	Inferred relationship	Some	5
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	Tenofovir alafenamide (substance)	false	Inferred relationship	Some	5
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength numerator value	dix	false	Inferred relationship	Some	5
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	Has unit of presentation	Tablet (unit of presentation)	true	Inferred relationship	Some
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	un	false	Inferred relationship	Some	1
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	This attribute specifies the denominator unit for the presentation strength of a product.	Tablet (unit of presentation)	true	Inferred relationship	Some	2
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	This attribute specifies the numerator unit for the presentation strength of a product.	mg	true	Inferred relationship	Some	4
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength numerator value	150	false	Inferred relationship	Some	2
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	un	false	Inferred relationship	Some	3
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	This attribute specifies the numerator unit for the presentation strength of a product.	mg	true	Inferred relationship	Some	3
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	This attribute specifies the numerator unit for the presentation strength of a product.	mg	true	Inferred relationship	Some	2
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	This attribute specifies the numerator unit for the presentation strength of a product.	mg	true	Inferred relationship	Some	1
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	un	false	Inferred relationship	Some	4
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	This attribute specifies the denominator unit for the presentation strength of a product.	Tablet (unit of presentation)	true	Inferred relationship	Some	3
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	This attribute specifies the denominator unit for the presentation strength of a product.	Tablet (unit of presentation)	true	Inferred relationship	Some	1
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength numerator value	150	false	Inferred relationship	Some	1
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	This attribute specifies the denominator unit for the presentation strength of a product.	Tablet (unit of presentation)	true	Inferred relationship	Some	4
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength denominator value	un	false	Inferred relationship	Some	2
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	Cobicistat	false	Inferred relationship	Some	1
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	Cobicistat	false	Inferred relationship	Some	1
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	Emtricitabine (substance)	false	Inferred relationship	Some	3
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength numerator value	200	false	Inferred relationship	Some	3
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	Elvitegravir (substance)	true	Inferred relationship	Some	2
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	Elvitegravir (substance)	true	Inferred relationship	Some	2
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	Emtricitabine (substance)	false	Inferred relationship	Some	3
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	Has presentation strength numerator value	dix	false	Inferred relationship	Some	4
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	Tenofovir alafenamide (substance)	false	Inferred relationship	Some	4
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	Tenofovir alafenamide (substance)	true	Inferred relationship	Some	4
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	quatre	false	Inferred relationship	Some
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	Is a	Product containing only cobicistat and elvitegravir and emtricitabine and tenofovir in oral dose form (medicinal product form)	true	Inferred relationship	Some
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	Plays role	Antiretroviral therapeutic role	false	Inferred relationship	Some
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	Cobicistat	true	Inferred relationship	Some	3
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	Emtricitabine (substance)	true	Inferred relationship	Some	1
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	Emtricitabine (substance)	true	Inferred relationship	Some	1
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	Cobicistat	true	Inferred relationship	Some	3
Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	Tenofovir alafenamide fumarate (substance)	true	Inferred relationship	Some	4

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
5183296017	Product containing precisely cobicistat 150 milligram and elvitegravir 150 milligram and emtricitabine 200 milligram and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 milligram/1 each conventional release oral tablet (clinical drug)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
5183299012	Cobicistat 150 mg and elvitegravir 150 mg and emtricitabine 200 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 10 mg oral tablet	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core